* Cellebrite DI Ltd CLBT.OQ CLBT.O is expected to show a
rise
in quarterly revenue when it reports results on August 8.
* The Petah Tikva Israel-based company is expected to
report a
15.9% increase in revenue to $72.523 million from $62.57 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cellebrite DI Ltd
is for
earnings of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cellebrite
DI Ltd
is $7.5, above its last closing price of $7.39.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.02 0.02 0.04 Beat 77.8
Dec. 31 2023 0.03 0.04 0.08 Beat 100
Sep. 30 2022 0.02 0.02 0.01 Missed -55.6
Jun. 30 2022 0.02 0.03 0.00 Missed -100
Mar. 0.02 0.02 0.01 Missed -55.6
31 2022
Dec. 31 2021 0.02 0.02 0.03 Beat 33.3
Sep. 30 2021 0.02 0.02 0.08 Beat 300
This summary was machine generated August 4 at 18:38 GMT. All
figures in US dollars unless otherwise stated